Grifols, S.A. (GRFS) Financials

GRFS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 23.4 billion 14.3 billion
2023-06-30 23.3 billion 14.4 billion
2023-03-31 23.5 billion 14.3 billion
2022-12-31 22.9 billion 14.1 billion

GRFS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 116.8 million ?
2023-06-30 -81.6 million ?
2023-03-31 -106.8 million ?
2022-12-31 ? ?

GRFS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-09-30 63.0 million
2023-06-30 56.6 million
2023-03-31 35.2 million
2022-12-31 34.7 million

GRFS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 575.5 million - -
2023-06-30 605.9 million - -
2023-03-31 630.7 million - -
2022-12-31 456.8 million - 1.1 billion

GRFS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 718.5 million
2023-06-30 707.4 million
2023-03-31 741.0 million
2022-12-31 728.1 million

GRFS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 47.9 million 93.6 million 317.9 million -
2023-06-30 35.6 million 94.9 million 317.6 million -
2023-03-31 83.7 million 115.8 million - -
2022-12-31 82.4 million 114.0 million 353.8 million -

GRFS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.7 billion 1.0 billion
2023-06-30 1.8 billion 1.1 billion
2023-03-31 1.9 billion 1.2 billion
2022-12-31 1.8 billion 1.2 billion

GRFS

Price: $6.57

52 week price:
5.30
12.15

Payout Ratio Range:
12.30%
88.54%

Earnings Per Share: 0.10 USD

P/E Ratio: 212.50

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 924384

Ebitda: 362.6 million

Market Capitalization: 5.6 billion

Average Dividend Frequency: 2

Links: